Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Pfizer & BioNTech partnership
View:
Post by 99942Apophis on Nov 22, 2021 8:52am

Pfizer & BioNTech partnership

BioNTech's partnership with Pfizer allowed their successful vaccine to be distributed worldwide. Could BioNTech have been able to distribute as rapidly or in as large volume probably not! Their partnership allowed BioNTech's stock listed on Nasdaq BNTX to go from a share price of $13.82 Oct. 7 2019 to a high of $389.01 on Aug. 2 2021.

Is Theralase already in negotiations with a suitable partner and at advanced stage or are they still accepting proposals from many suitors? My opinion doesn't matter although I do lean into the group here that believe a partnership might have already been established. 

We as shareholders can only guess what will transpire and the upcoming hard numbers will shed more light towards the future.
Comment by Infinity on Nov 22, 2021 10:56am
Agree,  a joint venture is the best case scenario.  There is no way that Biontech could have acheived worldwide marketing of their vaccine without Pfizer, not a chance.. However, to establish a really good joint venture, you need to have  1.  Excellent Clinical Test results.  Peer reviews of other Urological Oncologists who specialise in Blader cancer treatment.   ...more  
Comment by CAinPlap on Nov 22, 2021 11:40am
Careful. I got chastized for suggesting one more year. two? thats a paddlin'  :)
Comment by Infinity on Nov 22, 2021 12:30pm
Close to $4 or $5 mark in 2 years to be uplisted to major stock exchanges is very optimistic and doable, but not easy....Anyway paddlin it is!!
Comment by CancerSlayer on Nov 22, 2021 1:07pm
  Agree....a JV would be ideal, & not until we are FDA approved for this indication, on a real exchange & preferably sitting at least in the $5-10 range.  The real question is, how do we reasonably get there?   A BTD is a significant milestone achievement.  Though on this exchange, I expect it would lead to one small step-up in share price, yet one giant leap away ...more  
Comment by Oilminerdeluxe on Nov 22, 2021 1:15pm
All it takes is a reverse split. Sorry, couldn't resist. Not that anything ever goes smoothly with TLT, but this next update could be a very good time to present nice and solid news. Will they?  Waiting another quarter and then another is getting a horrid hobby for us all. A few more days to go. If we run to 30 cent, then maybe even a pessimistic sod like me starts to believe for real ...more  
Comment by chry200030 on Nov 22, 2021 1:28pm
Not enough shares for a reverse split. It will never happen. Pfizer has 5.6 billion shares. TLT could easily meet the uplist criteria if the right news comes out. It appears TLT is now headed for some serious price appreciation.  Like a train, when it departs it will not go 60 m.p.h. right away.
Comment by Oilminerdeluxe on Nov 22, 2021 1:30pm
It would be sweet ideed. We sure have earned it.
Comment by menoalittle on Nov 22, 2021 1:43pm
>> Like a train, when it departs it will not go 60 m.p.h. right away. quite true, short of a surprise announcement. not that I need any more ('cause at this point, it can only be catagorized as greed... lol), but nevertheless, parked a few bids out there just in case there's any mindless thoughts or efforts out there towards backing that train up a little.
Comment by CAinPlap on Nov 22, 2021 3:52pm
Can't wait for when we get days like SZLS is having today. Congrats to those who own as well.
Comment by socksnblonds642 on Nov 23, 2021 10:57am
Stage zero? I own. What's happening today? My app says it's down
Comment by 99942Apophis on Nov 22, 2021 5:48pm
I'm sure this has been posted before!   Graduation         Many companies that list on TSXV eventually grow to meet the listing requirements of TSX and choose to graduate to the senior board. Hundreds of companies have followed this path. In fact, one in five companies in the S&P/TSX Composite Index are graduates of TSXV.  ...more  
Comment by DJDawg on Nov 22, 2021 5:53pm
Is there a stock price or market cap requirement for moving up to the TSX from the venture exchange?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250